Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

532 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1.
Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. Border WA, et al. Among authors: ruoslahti e. Nature. 1990 Jul 26;346(6282):371-4. doi: 10.1038/346371a0. Nature. 1990. PMID: 2374609
L-arginine may mediate the therapeutic effects of low protein diets.
Narita I, Border WA, Ketteler M, Ruoslahti E, Noble NA. Narita I, et al. Among authors: ruoslahti e. Proc Natl Acad Sci U S A. 1995 May 9;92(10):4552-6. doi: 10.1073/pnas.92.10.4552. Proc Natl Acad Sci U S A. 1995. PMID: 7753841 Free PMC article.
Role of TGF-beta 1 in experimental glomerulonephritis.
Border WA, Okuda S, Nakamura T, Languino LR, Ruoslahti E. Border WA, et al. Among authors: ruoslahti e. Ciba Found Symp. 1991;157:178-89; discussion 189-93. Ciba Found Symp. 1991. PMID: 2070683 Review.
Transforming growth factor-beta 1 induces extracellular matrix formation in glomerulonephritis.
Border WA, Ruoslahti E. Border WA, et al. Among authors: ruoslahti e. Cell Differ Dev. 1990 Dec 2;32(3):425-31. doi: 10.1016/0922-3371(90)90059-6. Cell Differ Dev. 1990. PMID: 2099240 Review.
Coordinated expression of beta 1 integrins and transforming growth factor-beta-induced matrix proteins in glomerulonephritis.
Kagami S, Border WA, Ruoslahti E, Noble NA. Kagami S, et al. Among authors: ruoslahti e. Lab Invest. 1993 Jul;69(1):68-76. Lab Invest. 1993. PMID: 8331901
Localization of transforming growth factor beta binding site in betaglycan. Comparison with small extracellular matrix proteoglycans.
Fukushima D, Bützow R, Hildebrand A, Ruoslahti E. Fukushima D, et al. Among authors: ruoslahti e. J Biol Chem. 1993 Oct 25;268(30):22710-5. J Biol Chem. 1993. PMID: 8226781
Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.
Wolf YG, Rasmussen LM, Ruoslahti E. Wolf YG, et al. Among authors: ruoslahti e. J Clin Invest. 1994 Mar;93(3):1172-8. doi: 10.1172/JCI117070. J Clin Invest. 1994. PMID: 8132757 Free PMC article.
Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.
Hildebrand A, Romarís M, Rasmussen LM, Heinegård D, Twardzik DR, Border WA, Ruoslahti E. Hildebrand A, et al. Among authors: ruoslahti e. Biochem J. 1994 Sep 1;302 ( Pt 2)(Pt 2):527-34. doi: 10.1042/bj3020527. Biochem J. 1994. PMID: 8093006 Free PMC article.
Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.
Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA. Yamamoto T, et al. Among authors: ruoslahti e. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1814-8. doi: 10.1073/pnas.90.5.1814. Proc Natl Acad Sci U S A. 1993. PMID: 7680480 Free PMC article.
Vascular smooth muscle cells from injured rat aortas display elevated matrix production associated with transforming growth factor-beta activity.
Rasmussen LM, Wolf YG, Ruoslahti E. Rasmussen LM, et al. Among authors: ruoslahti e. Am J Pathol. 1995 Oct;147(4):1041-8. Am J Pathol. 1995. PMID: 7573349 Free PMC article.
532 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback